No Detail Found!

Assessing the Feasibility and Clinical Implications of multimarker RT-qPCR Profiling for Circulating Tumor Cell Detection in Breast Cancer Patients: A Pilot Study

Author(s)
Mehak Ali Kausar Abdullah Malik School of Life Sciences, Forman Christian College (A Chartered University), Lahore, Pakistan.
Hafiz Muhammad Haseeb Khaliq Kausar Abdullah Malik School of Life Sciences, Forman Christian College (A Chartered University), Lahore, Pakistan.
Amna Batool FMH College of Medicine and Dentistry, Fatima Memorial Hospital, Lahore, Pakistan.
Kausar Bano Department of Medical Oncology, Allama Iqbal Medical College/Jinnah Hospital Lahore, Pakistan.
Adnan Arshad Kausar Abdullah Malik School of Life Sciences, Forman Christian College (A Chartered University), Lahore, Pakistan.
Abstract
Objective: We primarily aimed to detect, isolate and enumerate circulating tumor cells with the help of a panel of markers in a cohort of breast cancer patients in Pakistani Population. Based on clinical utility of CTCs we build a comparison between level of CTCs before and after at least one cycle of chemotherapy monitoring the therapeutic response by using CTCs as Prognostic marker. Material and Methods: EDTA Blood samples of Breast cancer female patients were collected at two different time's points of their therapeutic regime. RNA was extracted and cDNA was synthesized. After isolation of CTCs, quantification of CTCs was determined with the help of a panel of markers (EpCAM, KRT & MAM) by using real time PCR during different time's points of chemotherapy along with the formation of conclusive statistical relationships. Results: Our multi-marker analysis for CTCs on the basis of selected biomarkers is strongly associated with cancer manifestations including treatment efficacy and predicting its potential measures to metastasize. We found increase in expression of the three markers for CTCs in metastatic breast cancer patients as compared to the ones on neo adjuvant and adjuvant chemotherapeutic regimes. Moreover, the level of CTCs varied with molecular subtypes. HER2neu have more CTCs as compared to Luminal classified cancers. Conclusion: It will help the clinicians not only in determining personalized chemotherapeutic regimen but also help in stratifying patients into low and high risk of developing metastasis. It will further help to devise anti-metastatic therapies and improving prognosis. The prospect of CTCs is to be provided with the platform of analysis beyond just enumeration.
Publication Details
Page(s) 1-7
Published Journal: National Journal of Medical and Health Sciences, Volume: 5, Issue: 1, Year: 2023

Request the full text from PASTIC

Keywords
RT-qPCR, Breast Cancer, Liquid Biopsy, HER2neu, CTCs
References
Addanki S.,Meas S.,Sarli V.N.,Singh B.,Lucci A. .2022 .Applications of circulating tumor cells and circulating tumor DNA in precision oncology for breast cancers. International journal of molecular sciences, 23(14) : 7843.
Arshad A.,Deutsch E.,Vozenin M.C. .2015 .Simultaneous irradiation of fibroblasts and carcinoma cells repress the secretion of soluble factors able to stimulate carcinoma cell migration. PLoS One, 10(1) : e0115447.
Azevedo A.S.,Follain G.,Patthabhiraman S.,Harlepp S.,Goetz J.G. .2015 .Metastasis of circulating tumor cells: favorable soil or suitable biomechanics, or both?. Cell adhesion & migration, 9, (5) : 345-356.
Bodai B.I.,Tuso P. .2015 .Breast cancer survivorship: a comprehensive review of long-term medical issues and lifestyle recommendations. The Permanente Journal, 19(2) : 48.
Chen L.,Bode A.M.,Dong Z. .2017 .Circulating tumor cells: moving biological insights into detection. Theranostics, 7(10) : 2606.
Deng Z.,Wu S.,Wang Y.,Shi D. .2022 .Circulating tumor cell isolation for cancer diagnosis and prognosis. EBioMedicine, 83 : .
Gold B.,Cankovic M.,Furtado L.V.,Meier F.,Gocke C.D. .2015 .Do circulating tumor cells, exosomes, and circulating tumor nucleic acids have clinical utility?: a report of the association for molecular pathology. The Journal of Molecular Diagnostics, 17(3) : 209-224.
Hanahan D. .2022 .Hallmarks of cancer: new dimensions. Cancer discovery, 12(1) : 31-46.
Hirbe A.C.,Uluçkan O.,Morgan E.A.,Eagleton M.C.,Prior J.L.,Piwnica-Worms D.,Trinkaus K.,Apicelli A.,Weilbaecher K. .2007 .Granulocyte colony-stimulating factor enhances bone tumor growth in mice in an osteoclast-dependent manner. Blood, 109(8) : 3424-3431.
Iliescu F.S.,Poenar D.P.,Yu F.,Ni M.,Chan K.H.,Cima I.,Cima I.,Iliescu C. .2019 .Recent advances in microfluidic methods in cancer liquid biopsy. Biomicrofluidics, 13(4) : .
Jeong Y.J.,Park S.H.,Jeon C.H.,Letters Oncology .2020 .Detection of circulating tumor cells in patients with breast cancer using the conditionally reprogrammed cell culture method and reverse transcription-PCR of hTERT and MAGE A1-6. , 20(4) : 1-1.
Liu J.,Lian J.,Chen Y.,Zhao X.,Du C.,Xu Y.,Hu H.,Rao H.,Hong X. .2021 .Circulating tumor cells (CTCs): a unique model of cancer metastases and non-invasive biomarkers of therapeutic response. Frontiers in Genetics, 12 : 734595.
Lozar T.,Gersak K.,Cemazar M.,Kuhar C.G.,Jesenko T.,Mehak T. .2019 .The biology and clinical potential of circulating tumor cells. Radiology and oncology, 53(2) : 131.
Makki J. .2015 .Diversity of breast carcinoma: histological subtypes and clinical relevance. Clinical medicine insights: Pathology, : CPath-S31563.
Markiewicz A.,Topa J.,Nagel A.,Skokowski J.,Seroczynska B.,Stokowy T.,WelnickaJaskiewicz M.,Zaczek A.J. .2019 .Spectrum of epithelial-mesenchymal transition phenotypes in circulating tumour cells from early breast cancer patients. Cancers, 11(1) : 59.
Mikulová V.,Kološtová K.,Zima T. .2011 .Methods for detection of circulating tumour cells and their clinical value in cancer patients. Folia Biol (Praha), 57(04) : 151-161.
Rack B.,Schindlbeck C.,Jückstock J.,Andergassen U.,Hepp P.,Zwingers T.,Friedl T.W.,Lorenz R.,Tesch H.,Fasching P.A.,Fehm T. .2014 .Circulating tumor cells predict survival in early average-to-high risk breast cancer patients. Journal of the National Cancer Institute, 106(5) : dju066.
Samina J.,Khan S.A.,Talat R.,Ullah N.,Ali M.,Ayub I.,Bugti F.S.,Mustafa M.Z. .2020 .Detection of Serum Associated Proteins as Diagnostic Biomarkers in Patients suffering from Lung Cancer. National Journal of Medical and Health Sciences, 2(1) : 15-22.
Shafiq A.,Moore J.,Suleman A.,Faiz S.,Farooq O.,Arshad A.,Tehseen M.,Zafar A.,Ali S.H.,Din N.U.,Loya A. .2020 .Elevated soluble galectin-3 as a marker of chemotherapy efficacy in breast cancer patients: A prospective study. International journal of breast cancer, : .
Toss A.,Mu Z.,Fernandez S.,Cristofanilli M. .2014 .CTC enumeration and characterization: moving toward personalized medicine. Annals of translational medicine, 2(11) : 108.
Wulfing P.,Borchard J.,Buerger H.,Heidl S.,Zanker K.S.,Kiesel L.,Brandt B. .2006 .HER2-positive circulating tumor cells indicate poor clinical outcome in stage I to III breast cancer patients. Clinical Cancer Research, 12(6) : 1715-1720.
Yap Y.S.,Leong M.C.,Chua Y.W.,Loh K.W.J.,Lee G.E.,Lim E.H.,Dent R.,Ng R.C.H.,Lim J.H.C.,Singh G.,Tan A. .2019 .Detection and prognostic relevance of circulating tumour cells (CTCs) in Asian breast cancers using a label-free microfluidic platform. PLoS One, 14(9) : e0221305.
0

Citations

0

Downloads

54

Views